Corcept Therapeutics | CORT - Current Assets

Stock Price
46.07
Daily Change
0.99 2.20%
Monthly
13.84%
Yearly
-35.76%
Q2 Forecast
45.14

Corcept Therapeutics reported $485.46M in Current Assets for its fiscal quarter ending in December of 2025.





Current Assets Change Date
Acadia Pharmaceuticals USD 1.06B 14.31M Dec/2025
Alaunos Therapeutics USD 2.68M 1.05M Sep/2025
ANI Pharmaceuticals USD 753.12M 54.72M Dec/2025
Ardelyx USD 382.32M 14.33M Dec/2025
Assertio Holdings USD 263.57M 53.36M Sep/2025
Aurora Cannabis CAD 445.84M 22M Dec/2025
BioMarin Pharmaceutical USD 3.95B 98.95M Dec/2025
Bristol-Myers Squibb USD 35.63B 2.41B Sep/2025
Canopy Growth CAD 524.67M 78.85M Dec/2025
Corcept Therapeutics USD 485.46M 55.67M Dec/2025
Eli Lilly USD 55.63B 6.44B Dec/2025
Esperion Therapeutics USD 462.57M 102.11M Dec/2025
J&J USD 59.17B 3.55B Mar/2026
Knight Therapeutics CAD 394.84M 5.86M Dec/2025
Lexicon Pharmaceuticals USD 101.9M 20.63M Dec/2025
Merck USD 47.56B 10.49B Sep/2025
Nektar Therapeutics USD 266.27M 15.09M Dec/2025
Novartis USD 30.46B 2.26B Dec/2025
Novartis USD 30.46B 2.26B Dec/2025
Omeros USD 69.65M 26.53M Jun/2025
Pacira USD 547.97M 14.78M Dec/2025
Pfizer USD 46.92B 3.22B Sep/2025
Supernus Pharmaceuticals USD 644.18M 50.29M Dec/2025
TG Therapeutics USD 630.76M 31M Dec/2025